Author: paroukatos

20 Aug

Posted at 09:38h in Στεφ. Νόσος-Καρδιακή Ανεπάρκεια by

Norman M. Kaplan At least in hypertension, there has never been a perfect clinical trial. By its nature, hypertension poses several barriers to the performance and interpretation of even the most carefully planned and conducted therapeutic trial. First and perhaps foremost, blood pressure is a constantly...

20 Aug

Posted at 09:36h in Στεφ. Νόσος-Καρδιακή Ανεπάρκεια by

Thomas Giles Ambulatory blood pressure monitoring enables the recording of the circadian rhythm of blood pressure under everyday circumstances, with the majority of individuals displaying diurnal variations in both systolic and diastolic blood pressures. During sleep, blood pressure in most people is between 10% and 20%...

20 Aug

Posted at 09:30h in Στεφ. Νόσος-Καρδιακή Ανεπάρκεια by

Jennifer G. Robinson, MD, MPH, and Nidhi Maheshwari, MBBS A "polypill" for the primary prevention of cardiovascular disease has been proposed. We estimated the projected benefit of a secondary prevention "poly-portfolio" strategy, including pharmacologic and lifestyle approaches for those with coronary heart disease (CHD) or stroke....

20 Aug

Posted at 09:27h in Στεφ. Νόσος-Καρδιακή Ανεπάρκεια by

Oscar H Franco, Luc Bonneux, Chris de Laet, Anna Peeters, Ewout W Steyerberg and Johan P MackenbachAbstract Objective: Although the Polypill concept (proposed in 2003) is promising in terms of benefits for cardiovascular risk management, the potential costs and adverse effects are its main pitfalls. The objective...